Role of BAX for outcome prediction in gastrointestinal malignancies.

about

Emerging role of N-myc downstream-regulated gene 2 (NDRG2) in cancer Bax is involved in the anticancer activity of Velcade in colorectal cancer.BAX and CDKN1A polymorphisms correlated with clinical outcomes of gastric cancer patients treated with postoperative chemotherapy.

P2860

Q26778509-15257DD9-9209-4D38-8C92-6AED04DFDF46 Q41623743-141DE1DA-2568-4BD1-9932-824B36DD33B7 Q54318640-1D973D09-88BE-4FB7-9236-F50A51946040

P2860

Role of BAX for outcome prediction in gastrointestinal malignancies.

Item

http://www.wikidata.org/entity/Q38108758

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Role of BAX for outcome prediction in gastrointestinal malignancies.

@en

type

Item

label

Role of BAX for outcome prediction in gastrointestinal malignancies.

@en

prefLabel

Role of BAX for outcome prediction in gastrointestinal malignancies.

@en

P1476

Role of BAX for outcome prediction in gastrointestinal malignancies

@en

P2093

Anna Tessari

http://www.w3.org/2001/XMLSchema#string

Elisa Ciurlia

http://www.w3.org/2001/XMLSchema#string

Flavia Melotti

http://www.w3.org/2001/XMLSchema#string

Francesca Valvo

http://www.w3.org/2001/XMLSchema#string

Gaia Bertarelli

http://www.w3.org/2001/XMLSchema#string

Ilaria Bossi

http://www.w3.org/2001/XMLSchema#string

Pamela Biondani

http://www.w3.org/2001/XMLSchema#string

P2860

TGFBR2 and BAX mononucleotide tract mutations, microsatellite instability, and prognosis in 1072 colorectal cancers

Tumor suppressor p53 is a direct transcriptional activator of the human bax gene

Expression of apoptosis-related markers and clinical outcome in patients with advanced colorectal cancer

Bax suppresses tumorigenesis and stimulates apoptosis in vivo

Formation of nuclear Bax/p53 complexes is associated with chemotherapy induced apoptosis.

Randomized trial of preoperative chemoradiation versus surgery alone in patients with locoregional esophageal carcinoma.

Analysis of the p53/BAX pathway in colorectal cancer: low BAX is a negative prognostic factor in patients with resected liver metastases.

Analysis of p53/BAX/p16(ink4a/CDKN2) in esophageal squamous cell carcinoma: high BAX and p16(ink4a/CDKN2) identifies patients with good prognosis.

Analysis of p53/BAX in primary colorectal carcinoma: low BAX protein expression is a negative prognostic factor in UICC stage III tumors.

Genetic dissection of apoptosis and cell cycle control in response of colorectal cancer treated with preoperative radiochemotherapy.

P2888

s12032-013-0610-z

P304

610

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S12032-013-0610-Z

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Alessandro Pellegrinelli

Valeria Musella

P577

2013-05-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

236934134

http://www.w3.org/2001/XMLSchema#string

P6179

1015809857

http://www.w3.org/2001/XMLSchema#string

P698

23700226

http://www.w3.org/2001/XMLSchema#string

Role of BAX for outcome prediction in gastrointestinal malignancies.

about

P2860

P2860

Role of BAX for outcome prediction in gastrointestinal malignancies.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P5875

P6179

P698

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P5875

P6179

P698